Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer.

[1]  G. Semenza,et al.  Hypoxia-inducible factor 1 and breast cancer metastasis , 2015, Journal of Zhejiang University-SCIENCE B.

[2]  S. Eschrich,et al.  A gene expression platform to predict benefit from adjuvant external beam radiation in resected non-small cell lung cancer , 2014, medRxiv.

[3]  T. Strom,et al.  Radiosensensitivity Index Shows Promise for Predicting Outcomes With Adjuvant Radiation in Resected Pancreatic Cancer Patients , 2014 .

[4]  S. Eschrich,et al.  Radiosensitivity Molecular Signature Is Predictive of Overall Survival in Glioblastoma , 2014 .

[5]  S. Eschrich,et al.  A Molecular Signature of Radiosensitivity (RSI) is an RT-specific Biomarker in Prostate Cancer , 2014 .

[6]  Jay R. Harris,et al.  Diseases of the Breast , 2014 .

[7]  M. Clemons,et al.  Evolution of sites of recurrence after early breast cancer over the last 20 years: implications for patient care and future research , 2013, Breast Cancer Research and Treatment.

[8]  Ana Lluch,et al.  Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. , 2012, Cancer treatment reviews.

[9]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[10]  M. Kerin,et al.  Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype , 2012, Breast Cancer Research and Treatment.

[11]  Yudi Pawitan,et al.  Validation of a Radiosensitivity Molecular Signature in Breast Cancer , 2012, Clinical Cancer Research.

[12]  Emmanuel Barillot,et al.  Search for a Gene Expression Signature of Breast Cancer Local Recurrence in Young Women , 2012, Clinical Cancer Research.

[13]  R Peto,et al.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials , 2011, The Lancet.

[14]  Barbara L. Smith,et al.  Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  W. Woodward,et al.  Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation , 2011, Annals of Surgical Oncology.

[16]  J. Deschênes,et al.  Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  T. Nielsen,et al.  Breast cancer subtypes and the risk of local and regional relapse. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  David Boulware,et al.  A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation. , 2009, International journal of radiation oncology, biology, physics.

[19]  Steven Eschrich,et al.  Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform. , 2009, International journal of radiation oncology, biology, physics.

[20]  G. Clark,et al.  Prognostic factors versus predictive factors: Examples from a clinical trial of erlotinib , 2008, Molecular oncology.

[21]  Laurence Collette,et al.  Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial , 2007 .

[22]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[23]  L Collette,et al.  Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? , 2003, European journal of cancer.

[24]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[25]  D A Hilton,et al.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. , 1999, Cancer research.

[26]  J. Gunther,et al.  Impact of Pretreatment Combined 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer , 2016 .

[27]  M. Morrow,et al.  Comprar Harris. Enfermedades de la Mama. 4Ed | C. K. Osborne | 9878496921627 | Lippincott Williams & Wilkins , 2010 .

[28]  Jong-Hyeon Jeong,et al.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002, The New England journal of medicine.